Agache I, Akdis CA, Akdis M, Brockow K, et al. EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old. Allergy 2022;77:17-38.
PMID: 34324716